Compounds and compositions for treating infection

Details Compounds and compositions for treating infection Compounds and compositions for treating infection

2007-09-06

2011-11-29

Cruz, Kathrien (Department: 1628)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

C514S419000, C514S280000, C514S307000, C514S299000, C514S292000, C514S414000, C514S215000, C514S314000, C514S285000, C514S453000, C514S257000

Reexamination Certificate

active

08067401

ABSTRACT:
Compounds from 14 Kenyan plants, including from the root ofDovyalis abyssinicaandClutia robustahave been characterized and isolated, and their uses are disclosed.

REFERENCES:
patent: 5178865 (1993-01-01), Ho et al.
patent: 5366725 (1994-11-01), Okubo et al.
patent: 5411733 (1995-05-01), Hozumi et al.
patent: 5837257 (1998-11-01), Tsai et al.
patent: 5989556 (1999-11-01), Tsai et al.
patent: 6455078 (2002-09-01), Wu
patent: 6696094 (2004-02-01), Wu
patent: 7329767 (2008-02-01), Dewis et al.
patent: 7674483 (2010-03-01), Chepkwony
patent: 2010/0189828 (2010-07-01), Chepkwony
patent: 1919490 (2007-03-01), None
patent: WO 2007/024510 (2007-03-01), None
Marion (The Alkaloids of the Indole Series, Council National of Researches of Ottawa, 1941, pp. 305-308, translated from French).
Edeoga (phytochemical constituents of some Nigerian medicinal plants, African Journal of Biotechnology vol. 4 (7) pp. 685-699, 2005).
U.S. Appl. No. 11/352,931, filed Feb. 13, 2006.
International search report issued Dec. 27, 2007 in connection with PCT Application No. pct/us2006/031355.
Written opinion of the international search authority issued Feb. 22, 2008 in connection with pct Application No. pct/us2006/031355.
International preliminary report on Patentability, issued Feb. 26, 2008 in connection with pct Application No. pct/us2006/031355.
Extended European search reporting issued Apr. 8, 2010 in connection with European Patent Application No. 06801240.0.
In Response to the Communication Dated Apr. 8, 2010 in connection with European Patent Application No. 06801240.0.
Notice of Allowance issued Aug. 18, 2011 in connection with U.S. Appl. No. 12/657,212, filed Jan. 15, 2010.
Response to Apr. 1, 2011 Office Action in connection with U.S. Appl. No. 12/657,212, filed Jan. 15, 2010.
Office Action issued Apr. 1, 2011 in connection with U.S. Appl. No. 12/657,212, filed Jan. 15, 2010.
Response to Oct. 13, 2010 Office Action in connection with U.S. Appl. No. 12/657,212, filed Jan. 15, 2010.
Office Action issued Oct. 13, 2010 in connection with U.S. Appl. No. 12/657,212, filed Jan. 15, 2010.
Notice of Allowance issued Oct. 19, 2009 in connection with U.S. Appl. No. 12/387,896, filed May 8, 2009.
Notice of Allowance issued Apr. 7, 2009 in connection with U.S. Appl. No. 11/352,931, filed Feb. 13, 2006.
Examiner Interview Summary Record issued Apr. 7, 2009 in connection with U.S. Appl. No. 11/352,931, filed Feb. 13, 2006.
Final Office Action issued Apr. 7, 2009 in connection with U.S. Appl. No. 11/352,931, filed Feb. 13, 2006.
Response to Feb. 8, 2008 Office Action in connection with U.S. Appl. No. 11/352,931, filed Feb. 13, 2006.
Office Action issued Feb. 8, 2008 in connection with U.S. Appl. No. 11/352,931, filed Feb. 13, 2006.
Response to Jul. 20, 2007 Office Action in connection with U.S. Appl. No. 11/352,931, filed Feb. 13, 2006.
Office Action issued Jul. 20, 2007 in connection with U.S. Appl. No. 11/352,931, filed Feb. 13, 2006.
Communication pursuant to rule 94(3) epc issued Oct. 15, 2010 in connection with European Patent Application No. 06801240.0.
In Response to the Communication Dated Oct. 15, 2010 in connection with European Patent Application No. 06801240.0.
Communication pursuant to rule 94(3) epc issued Sep. 12, 2011 in connection with European Patent Application No. 06801240.0; (Exhibit 23).
Asres et al., Antiviral Activity Against Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) of . . . Plants, Phytother, Res. 15, 62-69 (2001).
Baldascini, “Income generating opportunities arising from natural exosystems in Uganda; an overview.” The International Food Policy institute. 2002, p. 1-39.
Broutin et al. “Whooping Cough metapopulation Dynamics in tropical conditions: persistence impact of vaccination” Proc. R. Soc. Lond. B(suppl). 271. 2004. p. S302-S305.
Chang, et al., “Differential inhibition of reverse transcriptase and cellular DNA polymerase-α activities by lignans isolated . . . ” Antiviral Research, 27(4), 367-374 (1995).
Cos, et al., “Antiviral activity of Rwandan medicinal plants against human immunodeficiency virus type-1 (HIV-1)”, Phytomedicine, 9, 62-68 (2002).
Cos et al. “Further evaluation of Rwandan medicinal plant extracts for their antimicrobial and antiviral activities,” J Ethnopharmacol (2002) 79:155-163. Abstract only.
Cui et al., “Clinical efficacy of compound periploca liquid in treating condyloma acuminaturn and . . . ” Zhongguo Zhong Xi Yi Jie He Za Zhi (2005) 25:392-6. Abstract only.
DeBoer et al., “Anti-fungal and anti-bacterial activity of some herbal . . . ” J Ethnopharmacol (2005) Available online Nov. 11, 2004, vol. 96, p. 461-469. Abstract only.
Eloff, “Which extractant should be used for the screening and isolation of antimicrobial components from plants?” Journal of Ethnopharmacology (1998) 60:1-8. Abstract only.
Geyid et al, “Screening of some medicinal plants of Ethiopia for their anti-microbial properties and chemical profiles”, J. Ethnopharmacology (2005) 97:421-427, Abstract only.
Giday, “An ethnobotanical study of medicinal plants used by the Zay people in Ethiopia” , CBMs: s Skriftseria (2001) 1:81-99.
Houghton, et al., “A Clinical Evaluation of the Chinese Herbal Mixture ‘Aden-I’ for Treating Respiratory Infections”, Phytother. Res., 7(5), 384-386 (1993).
John, et al., “Synergistic Antiretroviral Activities of the Herb,Prunella vulgaris, with AZT, ddl, and ddc”, Abstr. Gen. Meet., Am. Sc. Microbiol., 94, 481 (1994).
Kane, et al., Methyl Gallate, “Methyl-3, 4, 5-trihydroxy-benzoate, is a Potent and Highly Specific Inhibitor of Herpes . . . ” Bioscience Report, 8, 85-94 (1988).
Kuritzkes, “Laboratory Tests for Monitoring HIV-1 infection”, HIV and Hepatitis,com, p. 1-24 (2001).
Kraft et ale , In vitro antiplasmodial evaluation of medicinal plants from Zimbabwe Phytotherapy Research (2003) 17:123-128. Abstract only.
Mulholland et ale , “The Chemistry of the Meliaceae and Ptaeroxylaceae of Southern and Eastern Africa and Madagascar” Current Organic Chemistry (2002) 4:1011-1054.
Nagai, et al., “Inhibition of influenza Virus Sialidas and Anti-influenza Virus Activity by Plant Flavonoids”, Chem. Pharm Bull. 38(5), 1329-1332 (1990).
Tabbe, et al., “Isolation, purification, and partial characterization of pruneilin, an anti-HIV component from . . . ”, Antiviral Research, , 263-273 (1989).
Takechi and Tanaka, “Purification and Characterization of Antiviral Substance from the Bud ofSyzygium aromatica”, Planta Medica, 42, 69-74 (1981).
Vecchiato, “Sociocultural Aspects of Tuberculosis Control in Ethiopis”, Medical Anthropology Quarterly, 11(2):183-201 (1997).
Verschaeve et al, “Investigation of the antimutagenic effects of selected South African medicinal plant extracts”, Toxicology in Vitro (2004) 18:29-35. Abstract only.
Wikipedia.org. Retrieved from the internet. <http://en.wikipedia.org/wiki/infectious—disease> Retrieved on Mar. 25, 2011. pp. 1-12.
Yamasaki, et al., “Screening Test of Crude Drug Extract on Anti-HIV Activity”, Yakugaku Zasshi, 113(11), 818-824 (1993).
Yao, et al., “Mechanism of Inhibition of HIV-1 Infection in Vitro by Purified Extract ofPrunella vulgaris”, Virology, 187(1), 56-62 (1992).
Yamada, “A Report on the Ethnobotany of the Nyindu in the Eastern Part of the Former Zaire” , African Study Monographs (1999) 20:1-72.

Affiliated with

Also associated with

Rating

Compounds and compositions for treating infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds and compositions for treating infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and compositions for treating infection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4307033